Accurate Prediction of Pathological Rectal Tumor Response after Two Weeks of Preoperative Radiochemotherapy Using 18F-Fluorodeoxyglucose-Positron Emission Tomography-Computed Tomography Imaging

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 392-399

  Janssen, Marco H M ^a   Öllers, Michel C ^a   Riedl, Robert G ^b   van den Bogaard, Jørgen ^a   Buijsen, Jeroen ^a   van Stiphout, Ruud G P M ^a   Aerts, Hugo J W L ^a   Lambin, Philippe ^a   Lammering, Guido ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Pathological response prediction; Preoperative radiochemotherapy; Rectal cancer; Repeated PET CT imaging; TRG

Indexed keywords

ACCURATE PREDICTION; AREA UNDER THE CURVES; COMPUTED TOMOGRAPHY; CT IMAGING; CUT-OFF VALUE; F-FLUORODEOXYGLUCOSE; INFLAMMATORY REACTION; OPTIMAL TIME; PATHOLOGICAL RESPONSE; PET IMAGING; PREDICTIVE ACCURACY; PREDICTIVE FACTORS; PROSPECTIVE STUDY; RADIOCHEMOTHERAPY; RECTAL CANCER; RESPONSE INDICES; STANDARDIZED UPTAKE VALUES; TIME POINTS; TREATMENT RESPONSE; TUMOR REGRESSION GRADES; TUMOR RESPONSE;

FORECASTING; POSITRON EMISSION TOMOGRAPHY; POSITRONS; TUMORS;

COMPUTERIZED TOMOGRAPHY;

CAPECITABINE; FLUORODEOXYGLUCOSE F 18;

ACCURACY; ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RECTUM CANCER; TREATMENT DURATION; TREATMENT RESPONSE;

AREA UNDER CURVE; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; REMISSION INDUCTION; ROC CURVE; STATISTICS, NONPARAMETRIC; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77951857225     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.030     Document Type: Article

References (28)

1. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
2. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
3. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
4. Valentini V., Coco C., Cellini N., et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 51 (2001) 371-383
5. Capirci C., Rampin L., Erba P.A., et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 34 (2007) 1583-1593
6. Capirci C., Rubello D., Chierichetti F., et al. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. AJR Am J Roentgenol 187 (2006) W202-W208
7. Vliegen R.F., Beets-Tan R.G., Vanhauten B., et al. Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?. Strahlenther Onkol 184 (2008) 457-464
8. Kalff V., Duong C., Drummond E.G., et al. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 47 (2006) 14-22
9. Amthauer H., Denecke T., Rau B., et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31 (2004) 811-819
10. Denecke T., Rau B., Hoffmann K.T., et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?. Eur Radiol 15 (2005) 1658-1666
11. Guillem J.G., Moore H.G., Akhurst T., et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining long term outcomes of rectal cancer. J Am Coll Surg 199 (2004) 1-7
12. Melton G.B., Lavely W.C., Jacene H.A., et al. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 11 (2007) 961-969
13. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47 (2006) 1241-1248
14. Rosenberg R., Herrmann K., Gertler R., et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 24 (2009) 191-200
15. Hindie E., Hennequin C., and Moretti J.L. Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: Prognostic value and possible role in patient management. Eur J Nucl Med Mol Imaging 34 (2007) 1576-1582
16. Beaulieu S., Kinahan P., Tseng J., et al. SUV varies with time after injection in (18)F-FDG PET of breast cancer: Characterization and method to adjust for time differences. J Nucl Med 44 (2003) 1044-1050
17. Ollers M., Bosmans G., van Baardwijk A., et al. The integration of PET-CT scans from different hospitals into radiotherapy treatment planning. Radiother Oncol 87 (2008) 142-146
18. Daisne J.F., Sibomana M., Bol A., et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
19. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 (1994) 2680-2686
20. Wieder H.A., Brucher B.L., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22 (2004) 900-908
21. Wieder H.A., Ott K., Lordick F., et al. Prediction of tumor response by FDG-PET: Comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. Eur J Nucl Med Mol Imaging 34 (2007) 1925-1932
22. Soret M., Bacharach S.L., and Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 48 (2007) 932-945
23. Kao P.F., Chou Y.H., and Lai C.W. Diffuse FDG uptake in acute prostatitis. Clin Nucl Med 33 (2008) 308-310
24. Park H.-H., Roh D.-W., Lyu K.Y., et al. Usefulness of dynamic 18F-FDG PET scan in lung cancer and inflammation disease. AJ Nucl Med Meeting Abstracts 48 (2007) 458P-
25. Zhuang H., Pourdehnad M., Lambright E.S., et al. Dual time point 18F-FDG PET imaging for differentiating malig-nant from inflammatory processes. J Nucl Med 42 (2001) 1412-1417
26. Keyes Jr. J.W. SUV: standard uptake or silly useless value?. J Nucl Med 36 (1995) 1836-1839
27. Lindholm P., Minn H., Leskinen-Kallio S., et al. Influence of the blood glucose concentration on FDG uptake in cancer: A PET study. J Nucl Med 34 (1993) 1-6
28. Crippa F., Gavazzi C., Bozzetti F., et al. The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: A PET study in liver metastases from colorectal carcinomas. Tumori 83 (1997) 748-752